Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Age-related neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD) are associated with substantial mortality and morbidity. The etiology and pathogenesis of these diseases are not fully understood, which impedes the development of new therapies. Emerging epidemiological evidence has revealed that environmental toxicants substantially contribute to the pathogenesis of diseases through mechanisms involving compromised endogenous detoxification systems. This review synthesizes epidemiological and clinical evidence from human studies elucidating the crucial role of detoxification impairment in AD and PD pathogenesis, complemented by mechanistic insights from preclinical models. We also discuss novel therapeutic strategies targeting nuclear receptor signaling pathways-particularly the pregnane X receptor (PXR)-to restore detoxification capacity and modify disease trajectories.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.